Can patients with hyperthyroidism receive the 9-valent vaccine?

Hyperthyroidism refers to an overactive thyroid. If the patient's condition is stable, generally speaking, they can receive the HPV 9-valent vaccine. However, under certain circumstances, such as an unstable condition or the presence of allergies, vaccination should not be performed. If in doubt, it is recommended to consult a doctor in advance. Detailed explanation is as follows:

With proper treatment, most indicators of hyperthyroidism can return to normal levels. When the condition is stable, the patient's immune system functions relatively normally. Under such circumstances, receiving the HPV 9-valent vaccine will not trigger severe immune reactions, and the vaccine can also achieve its intended immunization effect.

However, for patients with unstable hyperthyroidism or specific conditions such as allergies, it is not recommended to receive the HPV 9-valent vaccine. During an acute episode of hyperthyroidism, the patient's body is in a state of stress, and immune system function may be altered. Vaccination at this time might increase the risk of adverse reactions or affect the vaccine's immunogenicity. Additionally, patients who are allergic to any component of the HPV 9-valent vaccine should not receive it, to avoid triggering an allergic reaction that could endanger their health.

Prior to receiving the HPV 9-valent vaccine, patients with hyperthyroidism should consult a specialist physician to evaluate their condition and assess the risks associated with vaccination, ensuring that the vaccination is administered safely.